
Citispas P Oral Suspension
Marketer
Starsure Remedies
Salt Composition
Mefenamic Acid (50mg) + Paracetamol (125mg)
Overview Citispas P Oral Suspension
Pediatric Citispas oral suspension combines two active ingredients, both classified as non-steroidal anti-inflammatory drugs (NSAIDs). This formulation effectively reduces fever, pain, and inflammation (swelling and redness) in infants and children. Administer the prescribed dosage of Citispas P Oral Suspension to your child at the specified time and manner. Oral administration is recommended, ideally at a consistent time each day. While it may be given with or without food, post-meal administration minimizes the risk of stomach upset. If your child vomits within 30 minutes, repeat the same dose. Exceeding the recommended dosage for faster relief may lead to adverse effects. Minor side effects such as nausea, vomiting, stomach pain, indigestion, and diarrhea may occur; these are usually transient and self-limiting. However, persistent or troublesome side effects warrant immediate consultation with your child's physician. Prior to administering Citispas P Oral Suspension, inform your child's doctor of any known allergies, pre-existing heart conditions, congenital defects, liver, kidney, lung, or bleeding disorders. This information is crucial for accurate dosage determination and comprehensive treatment planning.
Uses of Citispas P Oral Suspension
Alleviating pain and reducing fever.
Major Benefits of Citispas P Oral Suspension:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always read the product label carefully before administering. Use a measuring device for accurate dosing and take it orally. Ensure thorough shaking prior to each use. Citispas P Oral Suspension can be ingested with or without food; however, consistent timing is recommended.
Common Side effects of Citispas P Oral Suspension:
- Nausea
- Vomiting
- Abdominal pain
- Heartburn
- Diarrhea
- Dizziness
How to use Citispas P Oral Suspension:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always refer to the product label for detailed administration guidelines. Use a measuring device for accurate dosing and take it orally. Ensure the suspension is thoroughly shaken before each use. Citispas P Oral Suspension can be administered with or without food; however, consistent timing is recommended.
How Citispas P Oral Suspension works:
Mefenamic acid and paracetamol, both non-steroidal anti-inflammatory drugs (NSAIDs), are the active components of Citispas P Oral Suspension. This formulation functions by inhibiting the production of chemical mediators responsible for the symptoms of fever, pain, and inflammation (characterized by redness and swelling).
SAFETY ADVICE
KidneyCAUTION
Patients with kidney impairment should use Citispas P Oral Suspension judiciously, potentially requiring dosage modification. Physician consultation is advised. Citispas P Oral Suspension is contraindicated in children exhibiting severe kidney dysfunction.
LiverSAFE IF PRESCRIBED
Citispas P Oral Suspension presents no known safety concerns for patients with hepatic impairment; dose modification is unnecessary. However, long-term use in children warrants routine monitoring of liver function through regular liver function tests (LFTs).
What if you forget to take Citispas P Oral Suspension :
Remain calm. Administer the forgotten dose upon recollection. Omit the missed dose, however, if the next dose is imminent or your pediatrician advised against supplementing missed doses. Avoid doubling the dose; adhere strictly to the recommended dosing regimen.
Facts to Know About Citispas P Oral Suspension
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
